Nuveen Asset Management LLC Sells 2,128 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Nuveen Asset Management LLC trimmed its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Rating) by 1.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 118,403 shares of the semiconductor company’s stock after selling 2,128 shares during the period. Nuveen Asset Management LLC’s holdings in Axcelis Technologies were worth $7,171,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Edmond DE Rothschild Holding S.A. raised its stake in shares of Axcelis Technologies by 4.8% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 3,134 shares of the semiconductor company’s stock valued at $172,000 after acquiring an additional 143 shares during the last quarter. Amalgamated Bank raised its stake in shares of Axcelis Technologies by 0.9% during the third quarter. Amalgamated Bank now owns 15,994 shares of the semiconductor company’s stock valued at $969,000 after acquiring an additional 144 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in shares of Axcelis Technologies by 0.7% during the first quarter. Great West Life Assurance Co. Can now owns 28,925 shares of the semiconductor company’s stock valued at $2,243,000 after acquiring an additional 209 shares during the last quarter. Guggenheim Capital LLC increased its position in shares of Axcelis Technologies by 8.5% during the first quarter. Guggenheim Capital LLC now owns 3,237 shares of the semiconductor company’s stock valued at $244,000 after buying an additional 253 shares during the period. Finally, Texas Permanent School Fund increased its position in shares of Axcelis Technologies by 1.2% during the second quarter. Texas Permanent School Fund now owns 23,901 shares of the semiconductor company’s stock valued at $1,311,000 after buying an additional 284 shares during the period. 86.47% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Tzu Yin Chiu sold 1,700 shares of the stock in a transaction that occurred on Wednesday, February 1st. The shares were sold at an average price of $127.12, for a total transaction of $216,104.00. Following the sale, the director now owns 28,873 shares in the company, valued at $3,670,335.76. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 2.15% of the company’s stock.

Axcelis Technologies Price Performance

Shares of ACLS opened at $123.69 on Monday. The stock has a market cap of $4.05 billion, a PE ratio of 22.65 and a beta of 1.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.56 and a current ratio of 3.54. Axcelis Technologies, Inc. has a fifty-two week low of $46.41 and a fifty-two week high of $135.96. The firm’s 50-day simple moving average is $112.87 and its two-hundred day simple moving average is $84.24.

Axcelis Technologies (NASDAQ:ACLS – Get Rating) last announced its quarterly earnings data on Thursday, February 9th. The semiconductor company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.25. The business had revenue of $266.05 million for the quarter, compared to analysts’ expectations of $251.80 million. Axcelis Technologies had a net margin of 19.90% and a return on equity of 30.16%. The business’s revenue was up 29.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.05 earnings per share. Analysts anticipate that Axcelis Technologies, Inc. will post 5.55 earnings per share for the current fiscal year.

Analyst Ratings Changes

ACLS has been the topic of several research analyst reports. StockNews.com cut shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 28th. Craig Hallum boosted their price target on shares of Axcelis Technologies from $113.00 to $140.00 and gave the company a “buy” rating in a research report on Friday, February 10th. Needham & Company LLC boosted their price target on shares of Axcelis Technologies from $100.00 to $140.00 and gave the company a “buy” rating in a research report on Friday, February 10th. B. Riley boosted their price target on shares of Axcelis Technologies from $115.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, February 10th. Finally, Benchmark reiterated a “buy” rating and set a $142.00 price target on shares of Axcelis Technologies in a research report on Tuesday, March 7th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies currently has an average rating of “Moderate Buy” and an average price target of $145.33.

Axcelis Technologies Profile

(Get Rating)

Axcelis Technologies, Inc engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. It ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training.